FindTrial
Sign In

Effect of salivary free Testosterone levels in women with Polycystic Ovarian syndrome

Association between salivary free Testosterone levels and serum Luteinizing Hormone, Follicular Stimulating Hormone, Testosterone levels in women with Polycystic Ovarian Syndrome â?? A Cross Sectional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032590
Enrollment
94
Registered
2021-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

None listed

Sponsors

Dr Rohini S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Newly diagnosed unmarried women with Polycystic Ovarian Syndrome 2.Women with Polycystic ovarian syndrome, as defined by Rotterdams criteria. 3.Women who give consent to participate will be included in the study.

Exclusion criteria

Exclusion criteria: 1.Woman having diabetes, hypertension, thyroid dysfunction, hyperprolactinemia, androgen-secreting tumours or receiving hormonal medication within 3 months before 2.Subjects with oral lesions and deleterious habits (tobacco chewing)

Design outcomes

Primary

MeasureTime frame
comparison of salivary free testosterone levels and serum Luetinizing Hormone, FSH and testosterone levels amongst Polycystic Ovarian Syndrome patientsTimepoint: At baseline—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDrRohini S

Ragas Dental College & Hospital

rohinistar37@gmail.com8940807510

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026